PsyBio Therapeutics Corp. (PSYBF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
PsyBio Therapeutics Market Cap
PsyBio Therapeutics has a market cap or net worth of $133 as of January 23, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
133.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 23, 2021, PsyBio Therapeutics's market cap has decreased from 38.24M to 133.00, a decrease of -100.00%. That is a compound annual growth rate of -93.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 133.00 | - |
| Dec 5, 2024 | 133.00 | -99.98% |
| Dec 29, 2023 | 583.50K | -80.15% |
| Dec 30, 2022 | 2.94M | -83.74% |
| Dec 31, 2021 | 18.07M | -52.73% |
| Apr 23, 2021 | 38.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 163.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| Q BioMed | 145.00 |
| NexImmune | 139.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |
| ContraFect | 107.00 |